News Releases

Marijuana industry press release distribution and publication; news topics include business, culture, politics, and science.

Why Coca Could Become the Next Superfood (and How to Invest)

  Superfoods refer to nutrient-rich foods that convey positive health benefits. While catechin-rich green tea, fisetin-rich strawberries, and omega-3-rich walnuts are well-known superfoods, coca leaves remain relatively undiscovered due to their association with cocaine. But fortunately, decocainized coca leaves open the...

Read MoreRead More

Heritage Cannabis Reports Q2 2022 Financial Results

TORONTO, June 28, 2022–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company“), today announced its financial results as at and for the three- and six-month periods ended April 30, 2022 (“Q2 2022“). All figures are in Canadian dollars...

Read MoreRead More

Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder

— Marks the first novel psilocybin analog to enter clinical development — — Patient recruitment to commence immediately — — Pharmacokinetic and safety data readout expected in Q4 2022 —     TORONTO, June 27, 2022–(BUSINESS WIRE)–Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (Cybin or the Company), a biopharmaceutical company...

Read MoreRead More

Artelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Pain

Presentation delivered by Professor Saoirse O’Sullivan at the 32nd Annual ICRS Symposium in Galway, Ireland on Sunday, June 26th   SOLANA BEACH, Calif., June 27, 2022 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for...

Read MoreRead More

PharmAla Biotech Registers Trademark for MDMA

The Company’s clinical-grade GMP MDMA product is now known as “Laneo”   VANCOUVER, June 24, 2022 (Canada Newswire) – PharmAla Biotech (CSE:MDMA) has registered a trademark for its clinical-grade MDMA product, which shall be marketed as Laneo MDMA. PharmAla is currently the...

Read MoreRead More